.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

The Evolving Treatment Landscape in Relapsed/Refractory Follicular Lymphoma

EP. 1: Dr. Patel on Factors to Consider When Treating Relapsed/Refractory Follicular Lymphoma

September 29th 2022

Krish Patel, MD, discusses the factors to consider when treating patients with relapsed and/or refractory follicular lymphoma.

EP. 2: Dr. Chedid on Understanding Treatment Efficacy in Follicular Lymphoma

September 29th 2022

Solly Chedid, MD, discusses the elements of effective therapy in follicular lymphoma.

EP. 3: Dr. Arora on the Evolution of Treatment in Follicular Lymphoma

September 29th 2022

Madan L. Arora, MD, discusses the evolution of treatment in follicular lymphoma.

EP. 4: The Evolving Treatment Landscape in Relapsed/ Refractory Follicular Lymphoma

November 4th 2022

On September 8, 2022, OncLive® brought together physicians who treat FL to participate in a virtual workshop and discuss the treatment landscape and management of patients with relapsed/refractory (R/R) FL. The discussion was led by Krish Patel, MD; perspectives and insights on current treatment options, trial data, and other novel therapies were exchanged.